Individual #00451662

ID_report 3bINP-104
Reference PubMed: Vela-Amieva 2024
Remarks -
Gender F
Consanguinity no
Country Mexico
Population Mexican
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases MSUD1A
Owner name Miriam Erandi Reyna-Fabián
Database submission license Creative Commons Attribution-ShareAlike 4.0 InternationalCreative Commons License
Created by Miriam Erandi Reyna-Fabián
Date created 2024-06-24 04:31:51 +02:00 (CEST)
Date last edited 2025-04-02 09:42:42 +02:00 (CEST)


Phenotypes

maple syrup urine disease, type Ia (MSUD1A)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Onset     

Phenotype/Onset     

Age/Diagnosis     

Protein     

Owner     
0000340323 Global developmental delay Maple syrup urine disease MSUD1A: Maple syrup urine disease, type II Familial, autosomal recessive - - - 00y03m - Miriam Erandi Reyna-Fabián



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000453266 DNA SEQ-NG-I gDNA from peripheral blood whole exome sequencing DBT 1 Miriam Erandi Reyna-Fabián



Variants

1 entry on 1 page. Showing entry 1.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
1 Both (homozygous) +?/. ACMG likely pathogenic (recessive) g.100696460_100696462del g.100230904_100230906del - - DBT_000041 This variant was classified as per ACMG guidelines (Richards et al 2015) and the recently developed ACMG scoring system (Tavtigian et al 2020). Nguyen et al 2020 reported a Vietnamese pediatric patient with maple sirup who presents this same variant in homozygous state (PMID:32515140). In silico analysis shows that the microdeletion occurs in the functional domain PLN02528 (2-oxoisovalerate dehydrogenase E2 component). The MutPred-indel program predicts it as deleterious: sp P11182 ODB2_HUMAN Lipoamide acyltransferase component: 0.7621 (>0.5 = deleterious) NA - The CADD program predicts it as also as deleterious: 21.0 (score "threshold" for deleterious >20). The Glu at position 88 of the DBT protein is evolutionarily conserved from human to C.elegans; Adhikari 2020:32778825, - ClinVar-527136 rs1217050849 Germline yes - - - - Miriam Erandi Reyna-Fabián DBT - - - - 4 NM_001918.2:c.263_265del - r.(?) p.(Glu88del) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.